SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The New Economy and its Winners

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Harmond who wrote (26486)11/30/2005 10:59:26 AM
From: bob zagorin  Read Replies (2) of 57684
 
wm, don't know if your still in foxh but here's GS today..

FoxHollow Technologies, Inc. EPS (FY Dec) 2005E ($0.53), 2006E $0.48 In-Line
(FOXH) $44.80
We are initiating coverage of FoxHollow Technologies with an IL/N rating.
FoxHollows SilverHawk plaque excision system has been a game-changer in the
treatment of peripheral artery disease. Its ability to safely clear out plaque buildup in
vessels significantly differentiates the technology from other minimally invasive
treatments. The SilverHawk launch in the US has been robust with revenues on track
to more than triple in 2005 to $132 million. We expect the ongoing ramp in
SilverHawk sales to be strong in the near-term and anticipate results to potentially
exceed expectations, driving shares towards our fair value estimate of $50. As such,
we position FOXH to be one of our favorite In-Line rated names. Our concerns are
longer-term in-nature, where increasingly challenging YoY comps could eventually
moderate share appreciation to be consistent with the average of our covered
universe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext